ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors

NCT01031212 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The investigator has left the institution (UCSF) prior to study start-up

Conditions

Tumors

Interventions

DRUG: ASA404
DRUG: Cetuximab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

University of California, San Francisco

Collaborators

[object Object]